Designs for Health, the trusted practitioner brand Learn More

Company Research Initiatives

Designs for Health has been the health care professional's trusted source since 1989.

Our Commitment to Advancing Science

We are driven by our belief that an evidence-based approach to integrative medicine will better the wellness of humanity

As part of our Science First philosophy and commitment to advancing the research and application of dietary compounds. Designs for Health is excited to support clinical trials in partnership with major academic and research institutions. These efforts investigate the nutrients and other compounds we leverage in our formulas and serve to expand the scientific understanding of their biological actions and influence on human health

Explore the array of research initiatives we support as an organization and scientific publications authored by our clinical team and members of our Scientific Advisory Board below

Science-Firstâ„¢

Science-Firstâ„¢

Research-Driven

Research-Driven

Evidence-Based

Evidence-Based

Scientific Publications

Our Scientific Advisory Board, clinical, and education teams contribute regularly to the scientific literature, as principal investigators and authors in established medical journals and scientific publications. These independently written articles have no affiliation to Designs for Health commercial endeavors, but support the broader scientific community's understanding of emerging trends and considerations in the realm of nutritional and functional medicine.

Log into your professional account to explore the array of research initiatives we support as an organization and a variety of scientific publications authored by our clinical team and members of our Scientific Advisory Board

Don't have a professional account? Register here today to access our superior, professional formulas, research and educational content, and
practice-building resources.

 

Research guides us. Wellness inspires us.

*Research Indirect Cost Rate: Designs for Health, Inc. acts as a private funder of clinical research on ingredients and finished products and has established an indirect cost rate of no more than 15% to all accepting funds for sponsored research.